Statement on Glucagen Hypokit supply 2 August 2023 Novo Nordisk has notified the Therapeutic Goods Administration that the Glucagen Hypokit is currently in a shortage that will last until 30 September 2023. The Glucagen Hypokit is used to treat severe hypoglycaemia where a person is unconscious or unable to take oral hypo treatments. If a person has a severe hypo and you don’t have a Hypokit you need to call 000 immediately. Diabetes Australia is working with the diabetes sector and the TGA to ensure people at highest risk are prioritized access to available supply. The TGA have also activated Section 19A provisions and is arranging imports of Hypokits from other countries. If you have concerns please talk to someone from your diabetes healthcare team.
News 14 May 2024 New PBS listing for treatment of itch associated with chronic kidney disease A new medication has been added to the PBS for people undergoing dialysis and experiencing chronic kidney disease itch. Continue Reading
News 10 May 2024 Urgent US recall on t:connect app American news media are reporting that the FDA issued a Class 1 recall of t:connect phone app after a malfunction caused pumps to shut down, suspending insulin delivery. Continue Reading
Blog 29 April 2024 Getting ready for the flu season: Vaccinate, please! Having the flu vaccine means you are less likely to become infected and, if you do become infected, you are more likely to only have a mild dose of the flu. Continue Reading